To ask Her Majesty's Government what assessment they have made of the use of steroid inhalers for the prevention of serious symptoms of COVID-19.
8 March 2021
The Department has monitored a collection of small studies which have now completed and provided some positive signals on inhaled steroids. This includes the STOIC study at Oxford University which examined the use of inhaled budesonide, a corticosteroid, in the treatment of early COVID-19. STOIC published results which are undergoing peer review. However, larger-scale studies are still needed to confirm the effectiveness and safety of such treatments.